Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for

Pupalan Iyngkaran1, William Chan2, Danny Liew3

  • 1Department of Cardiology, Flinders University, NT Medical School, Darwin 0810, Australia. balaniyngkaran@hotmail.com.

Insights

Screening for coronary artery disease (CAD) needs updated diagnostic approaches for diverse populations. This review examines non-invasive CAD diagnosis in multi-ethnic patients, considering new technologies and cost-effectiveness.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Public Health

Background:

  • Coronary artery disease (CAD) diagnosis relies on screening and diagnostic services.
  • Traditional research for CAD guidelines involved homogenous populations, predating current technologies.
  • Modern multi-ethnic populations present diverse risk factors potentially not reflected in existing evidence.

Purpose of the Study:

  • To review non-invasive diagnostic strategies for coronary artery disease (CAD).
  • To address the application of these strategies within diverse, multi-ethnic patient cohorts.
  • To consider the implications of evolving technologies and cost-effectiveness in CAD diagnosis.

Main Methods:

  • Review of current literature on non-invasive CAD diagnostic modalities.
  • Analysis of CAD diagnostic evidence in the context of multi-ethnic populations.
  • Discussion of translational challenges and cost-efficacy of diagnostic choices.

Main Results:

  • Existing CAD diagnostic guidelines may not fully align with the characteristics of diverse, multi-ethnic patient groups.
  • Newer technologies offer potential improvements in CAD screening and diagnosis.
  • Cost-effectiveness of first-line diagnostic tests requires careful consideration for varied populations.

Conclusions:

  • Non-invasive CAD diagnosis requires adaptation for multi-ethnic populations.
  • Translational research is crucial to ensure diagnostic guidelines are applicable across diverse demographics.
  • Optimizing diagnostic pathways involves balancing efficacy, cost, and patient diversity.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
426
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
368
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
684
Conservation of Small Populations02:04

Conservation of Small Populations

Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
17.1K